论文部分内容阅读
目的:研究新辅助化疗联合腹腔镜手术在直肠癌治疗中的临床实效性。方法:将128例直肠癌患者随机分组,观察组新辅助化疗联合腹腔镜手术治疗,对照组行腹腔镜手术和常规放化疗,两组护理方法相同,比较两组治疗效果差异。结果:观察组化疗后手术前治疗无效人数3(4.68%)例,总有效率为95.32%,术后排便功能优26(40.62%)例,良21(32.81%)例,中17(26.56%)例,差0(0.00%)例,与对照组相比存在显著差异,P<0.05。结论:新辅助化疗联合腹腔镜手术治疗直肠癌手术效果好,化疗不良反应少,患者预后好,值得推广借鉴。
Objective: To study the clinical efficacy of neoadjuvant chemotherapy combined with laparoscopic surgery in the treatment of rectal cancer. Methods: A total of 128 patients with rectal cancer were randomly divided into two groups: neoadjuvant chemotherapy combined with laparoscopic surgery in the observation group, laparoscopic surgery combined with conventional radiotherapy and chemotherapy in the control group, and the same nursing methods were compared between the two groups. Results: The total effective rate was 95.32%. The defecation function was excellent in 26 cases (40.62%), good in 21 cases (32.81%), moderate in 17 cases (26.56% ) Cases, poor 0 (0.00%) cases, there was significant difference compared with the control group, P <0.05. Conclusion: Neoadjuvant chemotherapy combined with laparoscopic surgery for rectal cancer surgery effect, less adverse reactions chemotherapy, patients with good prognosis, it is worth promoting reference.